LLY
Eli Lilly and Company
- Total liabilities, 2025
- $85.9B
- YoY, 2025
- +33.4%
- 5-year CAGR
- +16.1%
- 10-year CAGR
- +15.1%
Total liabilities
Total liabilities by fiscal year
| Period | Total liabilities | YoY |
|---|---|---|
| 2025 | $85.9B | +33.4% |
| 2024 | $64.4B | +21.3% |
| 2023 | $53.1B | +37.3% |
| 2022 | $38.7B | −2.4% |
| 2021 | $39.7B | −2.8% |
| 2020 | $40.8B | +11.5% |
| 2019 | $36.6B | +10.9% |
| 2018 | $33.0B | −0.9% |
| 2017 | $33.3B | +34.7% |
| 2016 | $24.7B | +17.9% |
| 2015 | $21.0B | +0.3% |
| 2014 | $20.9B | +18.8% |
| 2013 | $17.6B | −10.3% |
| 2012 | $19.6B | −2.5% |
| 2011 | $20.1B | +8.3% |
| 2010 | $18.6B | +3.6% |
| 2009 | $17.9B | −20.2% |
| 2008 | $22.5B | — |